ABSTRACT There is controversy regarding the application of angioplasty to patients with multivessel disease in whom all significant stenoses are not dilated. We analyzed the outcomes of 286 patients with multivessel disease and prior successful angioplasty at a mean follow-up duration of 26.2 months. End points analyzed included death, myocardial infarction, late revascularization, and angina pectoris. After successful angioplasty, 127 patients had no residual stenoses of 70% or greater (group 1) and 159 patients had one or more residual stenoses of 70% or greater (group 2). Because there were significant differences in baseline risk factors between the two groups, a logistic regression model was used to make the necessary adjustments in the analysis. Adjusted estimates of the risk of death, death/myocardial infarction, or presence of angina pectoris did not differ between the two groups. Group 2 patients, however, had more coronary artery bypass surgery during follow-up, while those in group 1 had more second PTCA procedures. Results suggest that angioplasty can be safely applied to patients with multivessel disease, even when all significant stenoses are not dilated. Circulation 77, No. 3, 638-644, 1988. WHILE percutaneous transluminal coronary angioplasty (PTCA) is the revascularization procedure of choice for patients with single-vessel disease, definitive criteria for its application in patients with multivessel coronary disease are still in evolution. Despite the increasing application of PTCA in these patients, there is concern regarding the long-term effects of the procedure, especially when all stenoses are not dilated.
WHILE percutaneous transluminal coronary angioplasty (PTCA) is the revascularization procedure of choice for patients with single-vessel disease, definitive criteria for its application in patients with multivessel coronary disease are still in evolution. Despite the increasing application of PTCA in these patients, there is concern regarding the long-term effects of the procedure, especially when all stenoses are not dilated.
Several studies of both angioplasty1' 2 and surgical therapy3-7 have suggested a poorer outcome in the latter cases.
This report from the NHLBI PTCA registry was designed to further assess the influence of the degree of revascularization in patients with multivessel cor-THERAPY AND PREVENTION-ANGIOPLASTY lesions in the posterior descending artery, second diagonal branch, or third obtuse marginal because of the relatively small amount of myocardium in jeopardy from these.
Multivessel disease was classified as9: type A, two or more vessels with stenoses of 70% or greater; type B, one vessel with a stenosis of 70% or greater and other vessel(s) with 50% to 70% lesions; type C, one or more complete occlusion(s) that are to be dilated plus other stenoses in which dilation may or may not be attempted; type D, one or more complete occlusion(s) not dilated plus other stenoses that are dilated.
Early results. Successful PTCA was defined as 20% or more improvement in luminal diameter of the proximal lesion inwhich the procedure is attempted without inhospital death or bypass surgery.
Patients were grouped by degree of revascularization as follows: group 1, successful PTCA with no remaining stenosis of 70% or greater in a vessel segment as defined above, and group 2, successful PTCA but with one or more residual stenoses of 70% or greater in a vessel segment as defined above.
Myocardial infarction was considered to have occurred when two or more of the three following criteria were met: clinical symptoms, elevated creative kinase (CK) greater than two times normal and/or CK-MB fragment, and development of definite Q wave by Minnesota code.10 Angina pectoris was defined by the Canadian Heart Classification.1' Unimproved angina denotes angina at follow-up the same or worse than that before the first PTCA procedure.
Patient selection. For the current study, patients were selected if they had multivessel disease and underwent successful angioplasty. Patients with prior coronary artery bypass graft surgery (CABG), left main disease, or with dilatation attempts of stenoses of less than 50% in luminal diameter were excluded. Two-hundred eighty-six patients formed the study group. The mean follow-up time was 26.2 months.
End points. To compare groups 1 and 2 in terms of untoward events and clinical status during follow-up, we considered a hierarchy of events: death, death/myocardial infarction, death/myocardial infarction/CABG, and death/myocardial infarction/CABG/second PTCA. The need for subsequent revascularization by CABG or PTCA or both was also a separate end point, regardless of whether a patient had myocardial infarction or subsequently died during the follow-up period.
Two clinical measures of symptomatic status were also considered. The first was presence of angina, as reported during the last follow-up interview, regardless of pre-PTCA symptomatic status. The second was the presence of angina, as reported during the last follow-up interview, that was the same or worse than that reported before PTCA (unimproved angina). We also considered each measure of symptomatic status in conjunction with the hierarchy of outcome events described above.
Statistical analysis. Thirty-four clinical, angiographic, hemodynamic, and dilatation variables were assessed. Chisquare significance tests were performed to ascertain imbalance in the distribution of the potential risk factors between the two comparison groups. The association between these risk factors and the follow-up events was also assessed by calculation of a chi-square statistic. Risk factors with imbalanced distributions and factors with strong or moderate associations with any of the outcome measures were included in the multivariate model. The estimated relative risk for events in the two groups was thus adjusted for known confounding factors so that any significant effects that were identified in the analysis could be reasonably attributed to the degree of revascularization itself Both death and myocardial infarction rates were higher in patients with residual stenosis and with the exception of second PTCA, occurrence of all other outcomes tended to be higher as well. This included the need for CABG and second PTCA, and that for CABG alone. While these procedures had to be performed twice as frequently in group 2, the proportion undergoing second PTCA without CABG was twice as high in group 1. It is noteworthy that the proportion who underwent at least one revascularization procedure (PTCA or CABG or both) was similar (33.1% vs 34.6%) in the two groups.
While in both groups about 30% of patients had angina at last follow-up, in a large percentage of patients in group 2 this represented unimproved pain.
In group 1, on the other hand, it represented recurrence or pain less severe than that before the first PTCA procedure.
Since group 2 patients had many more risk factors at baseline, the relative risk for each of the outcomes was computed ( infarction, Canadian Heart class III or IV at entry, age of 50 years or greater, and geometry of the lesion. The unadjusted risk of death or death/myocardial infarction was higher in group 2 (1.63 and 1.54 respectively), but after adjustment, the risk of death or death/myocardial infarction became lower in group 2. Angina at follow-up. The unadjusted and adjusted risk for presence of angina was essentially unity (table 3) . 640 However, patients with residual stenosis (group 2) had significantly more unimproved angina, both before and after adjustment. Relative risks were 3.6 and 3.5, respectively. Although group 2 patients had more unimproved angina, 82.9% of these patients were symptomatically improved at follow-up, as shown in In our study, differences in rates of mortality and morbidity for group 1 and group 2 patients could not be attributed to degree of revascularization when adjustments were made for the initial higher prevalence of ejection fraction less than 50%, Canadian Heart class III or IV angina, prior myocardial infarction, age greater than 50 years, and lesion eccentricity. This suggests that poorer results in those patients with remaining stenoses can, to a large extent, be explained by the generally higher prevalence of important risk factors in these patients rather than to the lesser degree of revascularization per se. In other words, patients in whom complete revascularization could not be performed had a poorer prognosis even before PTCA. Also, while the presence of more anatomic disease with preexisting total occlusion precluded complete revascularization, it did not affect the 2 year survival adversely, once other risk factors were controlled. TABLE 3 There were no apparent differences in the proportion of patients who underwent late procedures, second PTCA and/or CABG, when the two procedures were analyzed together as "any revascularization." However, CABG was twice as common in group 2 patients, while the incidence of second PTCA was 30% higher among patients in group 1. Group 2 had over twice as many patients (8.8% vs 4.0%) who underwent both late procedures. The selection of the type of late revascularization was likely mandated by the prior results of PTCA. That is, if all lesions were successfully dilated, the likelihood of successful repeat PTCA was judged to be high and the procedure undertaken again if additional revascularization was required. On balance, at least one second procedure was necessary in about one-third of the patients in both groups.
At last follow-up, approximately 30% of patients in both groups reported angina, but within groups, occurrence of unimproved angina was significantly higher in group 2 (13.4% vs 4.1%). Thus, while group 1 patients were just as likely to have angina, the angina was often less severe than that before PTCA.
In AAdjusted for ejection fraction <50%, prior myocardial infarction, Canadian Heart class III or IV, age 250 years, and geometry of lesion.
BAn estimated risk ratio equals 1 when the occurrence of events is the same in both groups. It is greater than 1 when events occur more frequently in group 2 (those with residual stenosis .70%) and less than 1 when events occur less frequently in group 2 in comparison with group 1 (those with no residual stenosis -70%). Second, the indications for late procedures in the two groups cannot be exactly identified but were presumably a combination of restenosis, inadequate initial revascularization, and new lesion formation, the latter being least likely. Other studies have shown that restenosis is the most likely cause of recurrent symptoms after successful multivessel angioplasty,'8 even when revascularization is incomplete,'9 and that the occurrence of restenosis, while variable, is probably increased in patients undergoing multivessel vs single-vessel angioplasty. The differences in incidence of unimproved angina noted in our current study may reflect in part a poorer tolerance of restenosis among those with initially less complete revascularization. While in this study a similar proportion of completely and incom-CIRCULATION THERAPY AND PREVENTION-ANGIOPLASTY pletely revascularized patients required repeat revascularization procedures (i.e., second PTCA or CABG), the disability, time, cost, and personnel requirements of surgery are clearly greater than those for angioplasty. From a patient's perspective, the two procedures would certainly not be of equal magnitude.
Third, relatively small numbers preclude further analysis of outcomes in various subsets of different revascularization status. Additionally, groups 1 and 2 are inherently different with respect to many preexisting characteristics. While we attempted to adjust for these differences, there may be imbalances in other unknown patient variables that exert bias in the results. A final limitation, common to all studies attempting to assess degree of revascularization, is a necessarily arbitrary coding system based on angiographic anatomy that may or may not correspond with physiologic extent of revascularization.
Clinical implications. While complete revascularization by angioplasty is an appealing concept, there are many patients in whom this goal cannot be achieved. Our results suggest that the negative outcomes commonly attributed to "incomplete revascularization" are in part due to more severe preexisting disease rather than degree of revascularization itself, and no increased risk of death or myocardial infarction could be attributed to less complete revascularization in this study. Clinically important improvement in symptomatic status was apparent at approximately 2 years of follow-up, with relatively modest differences by degree of revascularization. We conclude that, when applied to the subset of patients described in this report, angioplasty can 
